Arterial stiffness and renal replacement therapy

Peritoneal Dialysis International

Volumn 24, Issue 4, 2004, Pages 318-322

  Konings, Constantijn J A M ^a   Hermans, Marc ^b   Kooman, Jeroen P ^b   Meinders, Jan M ^c   Hoeks, Arnold P G ^c   van der Sande, Frank M ^b   Leunissen, Karel M L ^b  

^a CATHARINA HOSPITAL   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CALCINEURIN INHIBITOR; CALCIUM PHOSPHATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUINDOSTATIN; IMMUNOSUPPRESSIVE AGENT; PERINDOPRIL; PERITONEAL DIALYSIS FLUID; SEVELAMER;

ARTERY CALCIFICATION; ARTERY COMPLIANCE; ARTERY DIAMETER; ARTERY RESISTANCE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL OBSERVATION; COMMON CAROTID ARTERY; CREATININE CLEARANCE; DIALYSIS MEMBRANE; DISEASE ASSOCIATION; DOPPLER FLOWMETRY; EDITORIAL; ESSENTIAL HYPERTENSION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MEDICAL LITERATURE; MEDICAL RESEARCH; OUTCOMES RESEARCH; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PULSATILE FLOW; PULSE WAVE; YOUNG MODULUS;

EID: 4444256438     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080402400405     Document Type: Editorial

References (35)

1. London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996; 50:600-8.
2. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 11:2434-9.
3. Barenbrock M, Spieker C, Laske V, Heidenreich S, Hohage H, Bachmann J, et al. Studies of the vessel wall properties in HD patients. Kidney Int 1994; 45: 1397-400.
4. Konings CJ, Dammers R, Rensma PL, Kooman JP, Hoeks AP, Kornet L, et al. Arterial wall properties in patients with renal failure. Am J Kidney Dis 2002; 39: 1206-12.
5. Meeus F, Kourilsky O, Guerin AP, Gaudry C, Marchais SJ, London GM. Pathophysiology of cardiovascular disease in hemodialysis patients. Kidney Int Suppl 2000; 76:S140-7.
6. Mourad JJ, Pannier B, Blacher J, Rudnichi A, Benetos A, London GM, et al. Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int 2001; 59:1834-41.
7. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38:938-42.
8. Tycho Vuurmans JL, Boer WH, Bos WJ, Blankestijn PJ, Koomans HA. Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients. J Am Soc Nephrol 2002; 13: 177-83.
9. Lin YP, Yu WC, Hsu TL, Ding PY, Yang WC, Chen CH. The extracellular fluid-to-intracellular fluid volume ratio is associated with large-artery structure and function in hemodialysis patients. Am J Kidney Dis 2003; 42:990-9.
10. Kosch M, Barenbrock M, Kisters K, Rahn KH, Hausberg M. Relationship between muscle sympathetic nerve activity and large artery mechanical vessel wall properties in renal transplant patients. J Hypertens 2002; 20:501-8.
11. Zoccali C, Mallamaci F, Maas R, Benedetto FA, Tripepi G, Malatino LS, et al.; CREED Investigators. Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients. Kidney Int 2002; 62:339-45.
12. Ichihara A, Hayashi M, Ryuzaki M, Handa M, Furukawa T, Saruta T. Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus. Nephrol Dial Transplant 2002; 17:1513-17.
13. Beerenhout CM, Konings CJ, Dammers R, Rensma PL, Hoeks AP, Gladziwa U, et al. Determinants of arterial distensibility in patients with renal failure. Nephron Physiol 2003; 95:43-8.
14. Stewart AD, Millasseau SC, Kearney MT, Ritter JM, Chowienczyk PJ. Effects of inhibition of basal nitric oxide synthesis on carotid-femoral pulse wave velocity and augmentation index in humans. Hypertension 2003; 42:915-18.
15. Covic A, Goldsmith DJ, Gusbeth-Tatomir P, Buhaescu I, Covic M. Successful renal transplantation decreases aortic stiffness and increases vascular reactivity in dialysis patients. Transplantation 2003; 76:1573-7.
16. Barenbrock M, Hausberg M, Kosch M, Kisters K, Hoeks AP, Rahn KH. A longitudinal study of vessel wall properties in normotensive and hypertensive renal transplant recipients. J Hum Hypertens 1998; 12:707-11.
17. Ferro CJ, Savage T, Pinder SJ, Tomson CR. Central aortic pressure augmentation in stable renal transplant recipients. Kidney Int 2002; 62:166-71.
18. Lima JJ, Vieira ML, Viviani LF, Medeiros CJ, Ianhez LE, Kopel L, et al. Long-term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end-stage renal failure patients. Nephrol Dial Transplant 2002; 17:645-51.
19. Kosch M, Hausberg M, Suwelack B. Studies on effects of calcineurin inhibitor withdrawal on arterial distensibility and endothelial function in renal transplant recipients. Transplantation 2003; 76:1516-19.
20. Tsai PS, Yucha CB. Noninvasive measurement of central arterial pressure and distensibility by arterial applanation tonometry with a generalized transfer function: implications for nursing. Heart Lung 2001; 30:437-44.
21. O'Rourke MF, Staessen JA, Vlacapoulos C, Duprez D Plante GE. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens 2002; 15:426-44.
22. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001; 38:434-8.
23. Reneman RS, Hoeks AP. Noninvasive vascular ultrasound: an asset in vascular medicine. Cardiovasc Res 2000; 45:27-35.
24. Van Bortel LM, Balkestein EJ, van der Heijden-Spek JJ, Vanmolkot FH, Staessen JA, Kragten JA, et al. Non-invasive assessment of local arterial pulse pressure: comparison of applanation tonometry and echo-tracking. J Hypertens 2001; 19:1037-44.
25. Meinders JM, Hoeks AP. Simultaneous assessment of diameter and pressure waveforms in the carotid artery. Ultrasound Med Biol 2004; 30:147-54.
26. Konings CJ, Kooman JP, Schonck M, Dammers R, Cheriex E, Palmans Meulemans AP, et al. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int 2002; 22:477-87.
27. Bouthier JD, De Luca N, Safar ME, Simon AC. Cardiac hypertrophy and arterial distensibility in essential hypertension. Am Heart J 1985; 109:1345-52.
28. Bussy C, Boutouyrie P, Lacolley P, Challande P, Laurent S. Intrinsic stiffness of the carotid arterial wall material in essential hypertensives. Hypertension 2000; 35: 1049-54.
29. Laurent S, Hayoz D, Trazzi S, Boutouyrie P, Waeber B, Omboni S, et al. Isobaric compliance of the radial artery is increased in patients with essential hypertension. J Hypertens 1993; 11:89-98.
30. Mourad JJ, Girerd X, Boutouyrie P, Laurent S, Safar M, London G. Increased stiffness of radial artery wall material in end-stage renal disease. Hypertension 1997; 30:1425-30.
31. Balkestein EJ, van Aggel-Leijssen DP, van Baak MA, Struijker-Boudier HA, Van Bortel LM. The effect of weight loss with or without exercise training on large artery compliance in healthy obese men. J Hypertens 1999; 17:1831-5.
32. Suzuki H, Nakamoto H, Okada H, Sugahara S, Kanno Y. A selective angiotensin receptor antagonist, valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness. Adv Perit Dial 2003; 19:59-66.
33. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103:987-92.
34. Nakamura T, Kawagoe Y, Matsuda T, Takahashi Y, Sekizuka K, Ebihara I, et al. Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans. Kidney Blood Press Res 2003; 26:185-91.
35. Chertow GM, Burke SK, Raggi P; Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62:245-52.